News and Events Recent News Jul 14, 2021 Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Third Quarter Results Jul 14, 2021 Arrowhead Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) Jul 6, 2021 Arrowhead Announces Positive Interim Results from Phase 1b Study of ARO-HIF2 for Treatment of Clear Cell Renal Cell Carcinoma View More » Recent Events Aug 5, 2021 Arrowhead Pharmaceuticals 2021 Third Quarter Results Jun 25, 2021 28th Annual FSHD Society International Research Congress Jun 23, 2021 - Jun 26, 2021 The International Liver Congress™ 2021 - The Annual Meeting of the European Association for the Study of the Liver (EASL) View More »
Jul 14, 2021 Arrowhead Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Jul 6, 2021 Arrowhead Announces Positive Interim Results from Phase 1b Study of ARO-HIF2 for Treatment of Clear Cell Renal Cell Carcinoma
Jun 23, 2021 - Jun 26, 2021 The International Liver Congress™ 2021 - The Annual Meeting of the European Association for the Study of the Liver (EASL)